Late-Stage Product Development Pipeline for Differentiated Therapies Treating Central Nervous System Disorders


Orphan drug status in US and Europe

Therapeutic condition: Dravet syndrome, rare and catastrophic form of intractable epilepsy that begins in infancy
Formulation:  Low-dose fenfluramine
Status: Reported top-line phase 3 results Sept 2017
Latest data presented on ZX008